Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative evaluation of five different methods for the measurement of plasma factor II levels in carriers of the 20210A prothrombin variant.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Jul 2002

Delahousse B, Gilbert M, Nicham F, Thirion C, Giraudeau B, Gruel Y

Abstract excerpt

The common genetic G to A variation of the prothrombin gene is associated with elevated levels of prothrombin [factor II (FII)] and is recognized as a risk factor for thrombosis. To determine whether one type of assay for plasma FII measurement was more efficient than other assays in displaying high FII levels in 20210A carriers, we compared five methods of measuring FII levels [i.e. an enzyme-linked...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to Blood Coagulation Tests

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endopeptidases

Share to Factor VII

Share to Factor X

Share to Prothrombin

Share to ROC Curve

Share to Thrombophilia

Source

Identifiers

PMID: 12138376
DOI: 10.1097/00001721-200207000-00013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparative evaluation of five different methods for the measurement of plasma factor II levels in carriers of the 20210A prothrombin variant.PMID 12138376Read ↗

Clinical and Molecular Study of Common Thrombophilia Mutation Prothrombin G20210A.Semantic proximity Read ↗

Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant.Semantic proximity Read ↗

Factor V Leiden and FII 20210 testing in thromboembolic disorders.Semantic proximity Read ↗

Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene.Semantic proximity Read ↗

Routine coagulation tests are not useful as a screening tool for the FII G20210A polymorphism.Semantic proximity Read ↗

Reliable genotyping of the G-20210-A mutation of coagulation factor II (prothrombin).Semantic proximity Read ↗

Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3'-untranslated region of the prothrombin gene.Semantic proximity Read ↗

Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations.Semantic proximity Read ↗

A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.Semantic proximity Read ↗

The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis.Semantic proximity Read ↗

The first homozygous family for prothrombin G20210A polymorphism reported in Latin America.Semantic proximity Read ↗

Diagnostic Performance of Commercial Antithrombin Activity Assays: Do We Get What We Expect?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.